Christopher Sweeney
Impact in
-
- Drug Transport and Resistance Mechanisms
-
- Prostate Cancer Treatment and Research
- Sarcoma Diagnosis and Treatment
Papers in
-
- Prostate Cancer Treatment and Research 5
- Renal cell carcinoma treatment 2
- Oncology 4
- Colorectal Cancer Treatments and Studies 2
- Co-authors
- Karen Fife (1 shared paper)Ajai K. Chaudhary (1 shared paper)Isabelle Pouliquen (1 shared paper)Christopher A. Slapak (1 shared paper)Michael A. Gordon (1 shared paper)Linda A. Battiato (1 shared paper)Dinesh P. de Alwis (1 shared paper)Alan Sandler (1 shared paper)
- Journals
- Journal of Clinical Oncology (9 papers)Cancer Chemotherapy and Pharmacology (1 paper)Clinical Cancer Research (1 paper)Brachytherapy (1 paper)Oncology (1 paper)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Christopher Sweeney
15 papers receiving 279 citations
Peers
Comparison fields: 5 of 56
- Oncology 174
- Pulmonary and Respiratory Medicine 94
- Pediatrics, Perinatology and Child Health 41
- Radiation 16
- Pharmacology 13
Countries citing papers authored by Christopher Sweeney
This map shows the geographic impact of Christopher Sweeney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Sweeney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Sweeney more than expected).
Fields of papers citing papers by Christopher Sweeney
This network shows the impact of papers produced by Christopher Sweeney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Sweeney. The network helps show where Christopher Sweeney may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Sweeney, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 120 | |
| 2 | 2014 | 50 | |
| 3 | 2005 | 30 | |
| 4 | 2013 | 29 | |
| 5 | 2012 | 24 | |
| 6 | 2013 | 10 | |
| 7 | 2015 | 9 | |
| 8 | 2018 | 4 | |
| 9 | 2012 | 2 | |
| 10 | 2017 | 2 | |
| 11 | 2021 | 1 | |
| 12 | 2013 | 1 | |
| 13 | 2013 | 1 | |
| 14 | 2016 | 1 | |
| 15 | A phase I trial of the hemiasterlin analogue E7974 administered IV to patients with solid malignancies. | 2007 | 1 |
About Christopher Sweeney
Christopher Sweeney is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Pharmacology and Epidemiology, having authored 15 papers that have together received 285 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (5 papers), Colorectal Cancer Treatments and Studies (2 papers), Cancer, Lipids, and Metabolism (2 papers), Bladder and Urothelial Cancer Treatments (2 papers), Radiopharmaceutical Chemistry and Applications (2 papers), Renal cell carcinoma treatment (2 papers), Inflammatory mediators and NSAID effects (2 papers) and Multiple and Secondary Primary Cancers (2 papers). The work is most often cited by research in Oncology (174 citations), Pulmonary and Respiratory Medicine (94 citations), Pediatrics, Perinatology and Child Health (41 citations), Radiation (16 citations) and Pharmacology (13 citations). Christopher Sweeney has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Karen Fife, Ajai K. Chaudhary, Isabelle Pouliquen, Christopher A. Slapak, Michael A. Gordon, Linda A. Battiato, Dinesh P. de Alwis, Alan Sandler, Michael Burgess and Christopher Jordan. Their work appears in journals such as Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, Clinical Cancer Research, Brachytherapy and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.